SB273005 is primarily utilized in research settings to study its effects on integrin receptors, particularly αvβ3 integrin. It acts as a potent and selective antagonist, making it valuable for investigating the role of these receptors in various biological processes. Researchers use it to explore its potential in inhibiting angiogenesis, which is crucial in cancer studies, as blocking angiogenesis can limit tumor growth and metastasis. Additionally, it is employed in studies related to bone resorption and osteoporosis, as αvβ3 integrin plays a role in osteoclast function. Its application extends to understanding inflammatory diseases, where integrin-mediated cell adhesion and signaling are key factors. Overall, SB273005 serves as a critical tool in biomedical research for elucidating integrin-related pathways and developing therapeutic strategies.